Adagio Medical (ADGM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.10, -3.88% vs the prior close of $0.10.
- Volume 586.34K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ADGM slides 3.9% to $0.10. Closed at $0.10, -3.88% vs the prior close of $0.10. Day range $0.09–$0.11, opened at $0.10.
ADGM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ADGM slides 3.9% to $0.10
- Closed at $0.10, -3.88% vs the prior close of $0.10. Day range $0.09–$0.11, opened at $0.10.
- Volume was 586.34K shares, 0.3x its 50-day average of 2.26M — lighter than usual.
- Price is -76.6% vs its 50-day average ($0.42) and -87.5% vs its 200-day average ($0.79).
- 52-week range $0.08–$1.69; today's close sits at 1% of that range, 94.1% below the 52-week high.
Oct 15, 2026 — ADGM jumps 15.7% to $0.10 on 12.5x normal volume
- Closed at $0.10, +15.73% vs the prior close of $0.09. Day range $0.08–$0.11, opened at $0.09.
- Volume was 25.10M shares, 12.5x its 50-day average of 2.01M — unusually heavy trading.
- Price is -76.4% vs its 50-day average ($0.44) and -87.1% vs its 200-day average ($0.80).
- 52-week range $0.08–$1.69; today's close sits at 1% of that range, 93.9% below the 52-week high.
Oct 14, 2026 — ADGM slides 28.8% to $0.09, a 52-week low
- Closed at $0.09, -28.80% vs the prior close of $0.12. Day range $0.08–$0.13, opened at $0.12.
- Volume was 3.21M shares, 0.3x its 50-day average of 11.46M — lighter than usual.
- Price is -80.2% vs its 50-day average ($0.45) and -88.9% vs its 200-day average ($0.80).
- 52-week range $0.08–$2.02; today's close sits at 0% of that range, 95.6% below the 52-week high.
Oct 13, 2026 — ADGM slides 5.3% to $0.12, a 52-week low
- Closed at $0.12, -5.30% vs the prior close of $0.13. Day range $0.12–$0.14, opened at $0.13.
- Volume was 793.80K shares, 0.1x its 50-day average of 11.63M — lighter than usual.
- Price is -73.0% vs its 50-day average ($0.46) and -84.5% vs its 200-day average ($0.81).
- 52-week range $0.12–$2.12; today's close sits at 0% of that range, 94.1% below the 52-week high.
- SEC filings that day: DEF 14A.
Oct 12, 2026 — ADGM rises 1.5% to $0.13
- Closed at $0.13, +1.54% vs the prior close of $0.13. Day range $0.13–$0.14, opened at $0.13.
- Volume was 1.27M shares, 0.1x its 50-day average of 11.60M — lighter than usual.
- Price is -71.9% vs its 50-day average ($0.47) and -83.8% vs its 200-day average ($0.81).
- 52-week range $0.12–$2.58; today's close sits at 0% of that range, 94.9% below the 52-week high.
Oct 9, 2026 — ADGM ends flat (+0.0%) to $0.13, 6 down days in a row
- Closed at $0.13, +0.00% vs the prior close of $0.13. Day range $0.13–$0.13, opened at $0.13.
- Volume was 690.40K shares, 0.1x its 50-day average of 11.59M — lighter than usual.
- Price is -72.6% vs its 50-day average ($0.48) and -84.1% vs its 200-day average ($0.82).
- 52-week range $0.12–$2.58; today's close sits at 0% of that range, 95.0% below the 52-week high.
- That makes 6 straight losses.
Oct 8, 2026 — ADGM dips 3.0% to $0.13, a 52-week low, 5 down days in a row
- Closed at $0.13, -2.99% vs the prior close of $0.13. Day range $0.12–$0.13, opened at $0.13.
- Volume was 1.49M shares, 0.1x its 50-day average of 11.56M — lighter than usual.
- Price is -72.9% vs its 50-day average ($0.48) and -84.2% vs its 200-day average ($0.82).
- 52-week range $0.12–$2.58; today's close sits at 0% of that range, 95.0% below the 52-week high.
- That makes 5 straight losses.
Oct 7, 2026 — ADGM dips 2.9% to $0.13, a 52-week low, 4 down days in a row
- Closed at $0.13, -2.90% vs the prior close of $0.14. Day range $0.12–$0.14, opened at $0.14.
- Volume was 1.64M shares, 0.1x its 50-day average of 11.54M — lighter than usual.
- Price is -72.4% vs its 50-day average ($0.49) and -83.8% vs its 200-day average ($0.83).
- 52-week range $0.12–$2.58; today's close sits at 1% of that range, 94.8% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — ADGM dips 2.1% to $0.14, a 52-week low, 3 down days in a row
- Closed at $0.14, -2.13% vs the prior close of $0.14. Day range $0.13–$0.15, opened at $0.14.
- Volume was 1.56M shares, 0.1x its 50-day average of 11.50M — lighter than usual.
- Price is -71.9% vs its 50-day average ($0.49) and -83.4% vs its 200-day average ($0.83).
- 52-week range $0.12–$2.58; today's close sits at 1% of that range, 94.7% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — ADGM slides 7.8% to $0.14, a 52-week low
- Closed at $0.14, -7.84% vs the prior close of $0.15. Day range $0.14–$0.15, opened at $0.15.
- Volume was 1.63M shares, 0.1x its 50-day average of 11.47M — lighter than usual.
- Price is -71.7% vs its 50-day average ($0.50) and -83.1% vs its 200-day average ($0.84).
- 52-week range $0.12–$2.58; today's close sits at 1% of that range, 94.5% below the 52-week high.
Oct 2, 2026 — ADGM dips 1.9% to $0.15
- Closed at $0.15, -1.92% vs the prior close of $0.16. Day range $0.15–$0.16, opened at $0.16.
- Volume was 1.60M shares, 0.1x its 50-day average of 11.44M — lighter than usual.
- Price is -69.7% vs its 50-day average ($0.51) and -81.8% vs its 200-day average ($0.84).
- 52-week range $0.12–$2.58; today's close sits at 1% of that range, 94.1% below the 52-week high.
ADGM latest news & SEC filings
Every SEC filing by or about ADGM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mirsaeedi-Farahani Keyvan reported an other transaction of 12,770 shares on Sep 27, 2024; now holds 12,770
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
Oct 1, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.05 — Costs tied to exiting activities / restructuring.
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $0)
- Net income: -$6.72M (prior year -$3.95M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.30 (prior year -$0.35) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade ADGM
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Mar 27, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 9.25% (largest 53.1%). That is a volatile stock.
- Liquidity: about 4.87M shares (≈$482.58K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.10 vs a range of $0.08–$1.69 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Deborah Kaster bought 15,000 shares on Dec 16, 2025.
- Latest filings: 8-K Oct 1, 2026; 8-K Sep 23, 2026; 8-K Aug 14, 2026.
- Share count: 22.21M shares outstanding (Aug 10, 2026), +44.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
ADGM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.10 | 0.11 | 0.09 | 0.10 | 586.34K |
| Oct 15, 2026 | 0.09 | 0.11 | 0.08 | 0.10 | 25.15M |
| Oct 14, 2026 | 0.12 | 0.13 | 0.08 | 0.09 | 3.21M |
| Oct 13, 2026 | 0.13 | 0.14 | 0.12 | 0.12 | 793.80K |
| Oct 12, 2026 | 0.13 | 0.14 | 0.13 | 0.13 | 1.27M |
| Oct 9, 2026 | 0.13 | 0.13 | 0.13 | 0.13 | 690.40K |
| Oct 8, 2026 | 0.13 | 0.13 | 0.12 | 0.13 | 1.49M |
| Oct 7, 2026 | 0.14 | 0.14 | 0.12 | 0.13 | 1.64M |
| Oct 6, 2026 | 0.14 | 0.15 | 0.13 | 0.14 | 1.56M |
| Oct 5, 2026 | 0.15 | 0.15 | 0.14 | 0.14 | 1.63M |
| Oct 2, 2026 | 0.16 | 0.16 | 0.15 | 0.15 | 1.60M |
| Oct 1, 2026 | 0.16 | 0.18 | 0.15 | 0.16 | 7.73M |
| Sep 30, 2026 | 0.15 | 0.16 | 0.14 | 0.15 | 1.23M |
| Sep 29, 2026 | 0.18 | 0.18 | 0.12 | 0.14 | 2.23M |
| Sep 28, 2026 | 0.20 | 0.20 | 0.16 | 0.17 | 1.88M |
| Sep 25, 2026 | 0.22 | 0.22 | 0.19 | 0.19 | 2.09M |
| Sep 24, 2026 | 0.21 | 0.22 | 0.18 | 0.21 | 5.85M |
| Sep 23, 2026 | 0.33 | 0.35 | 0.21 | 0.23 | 36.57M |
| Sep 22, 2026 | 0.50 | 0.51 | 0.44 | 0.49 | 153.70K |
| Sep 21, 2026 | 0.52 | 0.52 | 0.46 | 0.50 | 128.30K |
About Adagio Medical
Adagio Medical (ADGM) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in LAGUNA HILLS, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2006986.
ADGM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| James L Cox | Director | Aug 12, 2026 |
| Sandra A. Gardiner | Director | Aug 12, 2026 |
| Orly Mishan | Director | Aug 12, 2026 |
| Keyvan Mirsaeedi-Farahani | Director | Aug 12, 2026 |
| Timothy P. Moran | Director | Aug 12, 2026 |
| Advisors Llc Perceptive | Director | Oct 22, 2025 |
| Sean Salmon | Director | Aug 12, 2026 |
| Todd Usen | Chief Executive Officer | Mar 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Deborah Kaster | Chief Financial Officer | Mar 9, 2026 |
| Todd Usen | Chief Executive Officer | Mar 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 16, 2025 | Deborah Kaster | Buy | 15,000 | $1.20 |
| Dec 16, 2025 | Deborah Kaster | Buy | 15,000 | $1.20 |
| Dec 16, 2025 | Deborah Kaster | Buy | 15,000 | $1.20 |
| Dec 16, 2025 | Deborah Kaster | Buy | 15,000 | $1.20 |
| Dec 12, 2025 | Todd Usen | Buy | 207,315 | $1.09 |
| Dec 12, 2025 | Todd Usen | Buy | 207,315 | $1.09 |
| Dec 12, 2025 | Todd Usen | Buy | 207,315 | $1.09 |
| Dec 12, 2025 | Todd Usen | Buy | 207,315 | $1.09 |
ADGM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $0 | $-25.08M | -1.51 | $-19.01M |
| Dec 31, 2023 | $300.00K | $-36.59M | -48.16 | $-25.65M |
Latest balance sheet: total assets $33.88M, total liabilities $34.30M, cash $7.74M (as of Jun 30, 2026).
ADGM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $0.72 |
| May 12, 2026 | 8-K Item 2.02 (results) | $0.92 |
| Mar 27, 2026 | 8-K Item 2.02 (results) | $1.22 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $0.85 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $1.27 |
| May 15, 2025 | 8-K Item 2.02 (results) | $1.22 |
| Apr 2, 2025 | 8-K Item 2.02 (results) | $0.81 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $3.71 |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ADGM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.